A study published by JAMA Aug. 13 found that a two-dose antibiotic treatment could be just as effective as traditional ...

A new way to battle bloodborne staph infections could help save lives while combating the rise of antibiotic-resistant ...

A National Institutes of Health (NIH)-supported clinical trial has found that the outcome of treating complicated ...

A randomized clinical trial set up to assess if dalbavancin is superior to standard treatment for Staphylococcus aureus ...

Among 200 patients, the probability of a more desirable day-70 outcome with two doses of intravenous dalbavancin versus 4 to 8 total weeks of standard therapy with an intravenous antibiotic was 47.7% ...

Researchers across 23 medical centers found a new two-dose treatment that could be as effective as standard treatment for complicated Staphylococcus aureus. The study was led by researchers from ...

Over-subscription of a topical antibiotic likely led to the emergence of a superbug which is now the leading cause of ...